Executive Vice President Francesca Boldrini

  • Connect
  • twitter
  • Contact
  • Print

Francesca is a respected award-winning leader in global health and development who brings unparalleled innovation and rigor to her work. Her twenty years plus experience working in public private partnerships make her a trusted advisor for senior leaders in the private sector, multilateral organizations, governments, NGOs and foundations.

At Rabin Martin, Francesca’s work focuses on supporting and continuing to grow our portfolio of European clients. She specializes in:


  • Designing strategies and implementation plans for public private partnerships
  • Leading the development of policy frameworks for private and public sector engagement in communicable (including vaccines, HIV/AIDS, TB and polio) and non-communicable diseases (including tobacco control and nutrition)
  • Developing innovative global health advocacy plans vis-à-vis European donor governments
  • Developing innovative market access strategies for emergency situations in emerging markets


Francesca previously served as the Head of Program Advocacy, Europe at the Bill & Melinda Gates Foundation (BMGF), where she played a key role in donor resource mobilization strategies for the first GAVI replenishment, the Abu Dhabi Vaccine Summit and the London Summit on Family Planning. Francesca has previously served as the Executive Director at Novartis Vaccines and Diagnostics, the Director of The Global Health Initiative at The World Economic Forum, as well as the European Brand Manager for Actonel at Procter & Gamble.

Francesca sits on the advisory board of the Human Foundation and is the Founding Partner and Principal of Hillgate Partners. She actively advises a number of organizations including the World Health Organization (WHO) and Comic Relief on their global health grant making portfolio. She is the author of the WHO guidelines for TB control in the workplace and of a number of other reports in collaboration with the Harvard School of Public Health and under the auspices of the World Economic Forum. She is currently a PhD candidate at the London School of Economics School of Government.



MSc Public Policy and Administration
London School of Economics

BA Hons Microbiology
University of Edinburgh